In 2023, Quest Diagnostics launched "Genetic Insights ... or a mix of both—to select the best DNA test kit for your needs. Prices are accurate and items in stock at time of publishing.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The acquisition of Haystack Oncology has strategically placed Quest Diagnostics in the higher-growth clinical area of ctDNA (Circulating tumor DNA) solid-tumor MRD (minimal residual disease) testing.

Citi analyst Patrick Donnelly raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $165 and keeps a Buy rating on the shares post the Q3 report. Integrating LifeLabs was the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We tried some of the top DNA testing services, assessing the breadth and depth of their offerings, methodologies, reputations and prices. Below, we'll break down the best DNA test options so you ...

Argus raised the firm’s price target on Quest Diagnostics (DGX) to $175 from $163 and keeps a Buy rating on the shares. The company reported strong Q3 results, reflecting higher healthcare ...

Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian ...

Biocept rose Tuesday after it said it would provide laboratory-testing services to lung-cancer patients of Quest Diagnostics. TheStreet talks with Food and Drug Administration expert about what to ...